Using the AKAP11 predicted diagnoses, we find that those most vulnerable to SCZ are males under 30 and those most vulnerable to BPD are females between 50 and 55, as can be seen from the largest frequencies in Fig. \ref{628883} and \ref{230418}.

We perform an F-test and Shapiro–Wilk Test for both diseases to ensure appropriate use of TOST.  Table \ref{stats-results} summarizes the p values obtained from these tests.  Since both data sets pass the Shapiro–Wilk Test, we reject the null hypothesis that the Canadian and AKAP11 data sets for SCZ and BPD are not normally distributed, which makes them both a suitable subject for t testing.  The bipolar data set does not pass the F-test, so we accept the null hypothesis that it has an unequal variance between the Canadian population and AKAP11 predicted results.  By extension, the bipolar data set requires an unequal variance t test and the schizophrenia data set requires a standard student’s t test.